Laurent Pouyet

Marseille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.

Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.

Journal: Open research Europe
Published: October 18, 2021

TP53INP1 deficiency maintains murine B lymphopoiesis in aged bone marrow through redox-controlled IL-7R/STAT5 signaling.

TP53INP1 deficiency maintains murine B lymphopoiesis in aged bone marrow through redox-controlled IL-7R/STAT5 signaling.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 19, 2018

NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.

NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.

Journal: Gut
Published: August 10, 2018

JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia.

JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia.

Journal: Cancer research
Published: May 02, 2017

BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia.

BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia.

Journal: Oncoimmunology
Published: December 18, 2015

Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy.

Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy.

Journal: Blood
Published: July 06, 2015

Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1.

Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1.

Journal: EMBO molecular medicine
Published: April 02, 2015

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia.

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia.

Journal: Blood cancer journal
Published: January 19, 2015

Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL.

Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL.

Journal: Oncotarget
Published: June 17, 2014

The thymus-specific serine protease TSSP/PRSS16 is crucial for the antitumoral role of CD4(+) T cells.

The thymus-specific serine protease TSSP/PRSS16 is crucial for the antitumoral role of CD4(+) T cells.

Journal: Cell reports
Published: February 27, 2014

TAp73 is required for macrophage-mediated innate immunity and the resolution of inflammatory responses.

TAp73 is required for macrophage-mediated innate immunity and the resolution of inflammatory responses.

Journal: Cell death and differentiation
Published: September 15, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026